Literature DB >> 8221032

Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease.

K F Gey1.   

Abstract

Free radicals may be involved in the aetiology of cancer and cardiovascular diseases. In epidemiological studies poor plasma levels of all essential antioxidants are associated with increased relative risks; in particular, low levels of carotene and vitamin E with the risk of cancer and ischemic heart disease, respectively. The studies suggest that for optimal synergistic protection the plasma antioxidant levels should simultaneously exceed the threshold values of 28-30 mumol/l lipid-standardized vitamin E, 40-50 mumol/l vitamin C, 0.4-0.5 mumol/l carotene and 2.2-2.8 mumol/l lipid-standardized vitamin A. However the preventive efficacy of an optional antioxidant status is still to be proven in randomized intervention trials. Although these antioxidant micronutrients may be the primary protective components of vegetable-rich 'preventive' diets, the potentials of other plant components await exploration, eg carotenoids other than beta-carotene, bioflavonoids and oxygen-sensitive B-vitamins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221032     DOI: 10.1093/oxfordjournals.bmb.a072640

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  23 in total

1.  Colorectal adenomas and diet: a case-control study. Colorectal Adenoma Study Group.

Authors:  B Breuer-Katschinski; K Nemes; A Marr; B Rump; B Leiendecker; N Breuer; H Goebell
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Beta-carotene intake and risk of nonfatal acute myocardial infarction in women.

Authors:  A Tavani; E Negri; B D'Avanzo; C La Vecchia
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

3.  Eicosapentaenoic acid and docosahexaenoic acid selectively attenuate U46619-induced smooth muscle cell proliferation.

Authors:  R Pakala; R Pakala; C Benedict
Journal:  Lipids       Date:  1999-09       Impact factor: 1.880

4.  Serum antioxidant and cholesterol levels in patients with different types of cancer.

Authors:  C Abiaka; F Al-Awadi; H Al-Sayer; S Gulshan; A Behbehani; M Farghally; A Simbeye
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

5.  Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile.

Authors:  Sridevi Devaraj; Sonia Vega-López; Nalini Kaul; Frank Schönlau; Peter Rohdewald; Ishwarlal Jialal
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

Review 6.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

7.  Protective effects of garlic and silymarin on NDEA-induced rats hepatotoxicity.

Authors:  Sabry M Shaarawy; Amany A Tohamy; Saad M Elgendy; Zakaria Y Abd Elmageed; Abeer Bahnasy; Maha S Mohamed; Emad Kandil; Khalid Matrougui
Journal:  Int J Biol Sci       Date:  2009-08-11       Impact factor: 6.580

8.  Association between low-level environmental arsenic exposure and QT interval duration in a general population study.

Authors:  Irina Mordukhovich; Robert O Wright; Chitra Amarasiriwardena; Emmanuel Baja; Andrea Baccarelli; Helen Suh; David Sparrow; Pantel Vokonas; Joel Schwartz
Journal:  Am J Epidemiol       Date:  2009-08-21       Impact factor: 4.897

9.  Exploring the Potential Role of Chemopreventive Agent, Hesperetin Conjugated Pegylated Gold Nanoparticles in Diethylnitrosamine-Induced Hepatocellular Carcinoma in Male Wistar Albino Rats.

Authors:  Krishnan Gokuladhas; Subramaniyan Jayakumar; Balan Rajan; Ramasamy Elamaran; Chengalvarayan Subramani Pramila; Mani Gopikrishnan; Sasivarman Tamilarasi; Thiruvengadam Devaki
Journal:  Indian J Clin Biochem       Date:  2015-10-06

10.  The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention.

Authors:  Leo R Zacharski; Ralph G DePalma; Galina Shamayeva; Bruce K Chow
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.